ArticleMalaria journal2014

Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds.

Sean R Marcsisin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.